JVTF EFS
J-Valve TF Early Feasibility Study
AI Description
The main objective of this study is to assess the preliminary safety and effectiveness of the J-Valve TF System in patients with symptomatic severe native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open surgical aortic valve replacement.
- Who can join
- child, adult, older adult
- Participants
- 25
- Expected completion
- 2029-08-25
- Funded by
- industry
Conditions studied
Aortic Regurgitation, Aortic Valve Disease, Aortic Valve Insufficiency
What is being tested
- DEVICE: J-Valve TF System
What it measures
- Number of patients that do not experience death or disabling stroke, Freedom from death or disabling stroke Disabling stroke is evaluated using a standardized scale, 30 days after the valve procedure
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Advocate Christ Medical Center (Oak Lawn)
Oak Lawn, IL
HonorHealth Scottsdale Shea Medical Center
Scottsdale, AZ
Houston Methodist Hospital
Houston, TX
Kaleida Health
Buffalo, NY
MedStar Washington Hospital Center
Washington, DC
Montefiore Einstein Hospital (Moses Campus)
Bronx, NY
Swedish Cherry Hill Campus
Seattle, WA
The Christ Hospital
Cincinnati, OH
Registry entry updated 2025-07-11
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.